Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative recovery after elective gynecologic laparoscopy
ChiCTR2400090783Phase 4Not yet recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoints: Quality of Recovery-15 score at 24 hours postoperatively, Total amount of analgesic delivered by patient-controlled analgesia pump and 1 more. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400090783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090783.